Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP09178428Aexternal-prioritypatent/EP2192120B1/en
Application filed by Merck & CiefiledCriticalMerck & Cie
Publication of CY1112161T1publicationCriticalpatent/CY1112161T1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Medicinal Preparation
(AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Abstract
Η εφεύρεση αναφέρεται σε σταθερό κρυσταλλικό μετά ασβεστίου άλας του 5-μεθυλο-(6S)-τετραϋδροφολικού οξέος, σε μέθοδο για την παραγωγή αυτού του άλατος καθώς και στη χρήση αυτού ως συστατικό για την παραγωγή φαρμακευτικών μέσων, ως συμπλήρωμα διατροφής και σε παρασκευάσματα που περιέχουν αυτό το άλας.The invention relates to a fixed calcium crystalline salt of 5-methyl- (6S) -tetrahydrofolic acid, to a method for the production of this salt and to its use as an ingredient in the manufacture of pharmaceuticals, as a food supplement and in preparations containing this salt.
CY20111101182T1999-04-152011-11-30
STABLE CRYSTAL CALCULATE AFTER CALCIUM SALT TOY 5-METHYLO- (6S) - tetrahydrofolic acid
CY1112161T1
(en)
Crystalline anhydrous aripiprazole d, method for production thereof, pharmaceutical composition containing crystalline anhydrous aripiprazole d, and method for production thereof